Evidence map›Paper›PMID 41300908›Full record

ReviewDiagnostics (Basel, Switzerland)2025

The Role of Exhaled Breath Analyses in Interstitial Lung Disease.

Panaiotis Finamore, Alessio Marinelli, Simone Scarlata, Silvano Dragonieri, Andras Bikov

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Panaiotis FinamoreUnit of Internal Medicine, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.ORCID 0000-0002-8608-9223
Alessio MarinelliDepartment of Respiratory Diseases, University of Bari, 70121 Bari, Italy.ORCID 0009-0008-7779-7931
Simone ScarlataUnit of Internal Medicine, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Roma, Italy.ORCID 0000-0002-2704-2708
Silvano DragonieriDepartment of Respiratory Diseases, University of Bari, 70121 Bari, Italy.ORCID 0000-0003-1563-6864
Andras BikovWythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester M23 9LT, UK.ORCID 0000-0002-8983-740X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interstitial lung diseases (ILDs) represent a group of lung disorders that primarily affect the lung parenchyma. These disorders are usually progressive, may be debilitating and life threatening, and often pose diagnostic and therapeutic challenges. Exhaled breath analyses offer opportunity for diagnosis, differential diagnosis, and to predict prognosis and treatment outcomes. Numerous studies have been published using various exhaled biomarker analyses, including exhaled nitric oxide, exhaled breath condensate, and exhaled volatile organic compounds. This review summarises and critically appraises the literature and offers suggestions for further research to apply exhaled biomarker analyses in clinical practice.

Indexed as

breathprintEBCILDVOC

Identifiers

PMID41300908
PMCPMC12651493

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.